JP2005538692A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538692A5
JP2005538692A5 JP2003578392A JP2003578392A JP2005538692A5 JP 2005538692 A5 JP2005538692 A5 JP 2005538692A5 JP 2003578392 A JP2003578392 A JP 2003578392A JP 2003578392 A JP2003578392 A JP 2003578392A JP 2005538692 A5 JP2005538692 A5 JP 2005538692A5
Authority
JP
Japan
Prior art keywords
nucleic acid
cap
group
sequence selected
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003578392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538692A (ja
Filing date
Publication date
Priority claimed from US10/105,871 external-priority patent/US7700274B2/en
Application filed filed Critical
Publication of JP2005538692A publication Critical patent/JP2005538692A/ja
Publication of JP2005538692A5 publication Critical patent/JP2005538692A5/ja
Withdrawn legal-status Critical Current

Links

JP2003578392A 2002-03-20 2003-03-12 Kcnj9の異常発現に関連する癌における新規組成物および方法 Withdrawn JP2005538692A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/105,871 US7700274B2 (en) 2000-12-22 2002-03-20 Compositions and methods in cancer associated with altered expression of KCNJ9
PCT/US2003/007469 WO2003080639A1 (en) 2002-03-20 2003-03-12 Novel compositions and methods in cancer associated with altered expression of kcnj9

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009133821A Division JP2009232852A (ja) 2002-03-20 2009-06-03 Kcnj9の異常発現に関連する癌における新規組成物および方法

Publications (2)

Publication Number Publication Date
JP2005538692A JP2005538692A (ja) 2005-12-22
JP2005538692A5 true JP2005538692A5 (enExample) 2006-04-20

Family

ID=28452450

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003578392A Withdrawn JP2005538692A (ja) 2002-03-20 2003-03-12 Kcnj9の異常発現に関連する癌における新規組成物および方法
JP2009133821A Pending JP2009232852A (ja) 2002-03-20 2009-06-03 Kcnj9の異常発現に関連する癌における新規組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009133821A Pending JP2009232852A (ja) 2002-03-20 2009-06-03 Kcnj9の異常発現に関連する癌における新規組成物および方法

Country Status (6)

Country Link
US (2) US7700274B2 (enExample)
EP (1) EP1490388A4 (enExample)
JP (2) JP2005538692A (enExample)
AU (2) AU2003225750C1 (enExample)
CA (1) CA2479727A1 (enExample)
WO (1) WO2003080639A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005054863A2 (en) * 2003-11-22 2005-06-16 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled inwardly rectifying potassium channel (girk 3)

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4640835A (en) * 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US5430136A (en) * 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US5235033A (en) * 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
EP0206448B1 (en) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
EP0272253A4 (en) 1986-03-07 1990-02-05 Massachusetts Inst Technology METHOD FOR IMPROVING GLYCOPROTE INSTABILITY.
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
CA2049028A1 (en) 1989-03-07 1990-09-08 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
US5014802A (en) * 1990-06-04 1991-05-14 General Motors Corporation Rear steer controller
US5602240A (en) * 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5386023A (en) * 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) * 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
KR100272077B1 (ko) * 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5644048A (en) * 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
WO1993022443A1 (en) 1992-04-24 1993-11-11 Sri International In vivo homologous sequence targeting in eukaryotic cells
US5681697A (en) * 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
US5637684A (en) * 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5597909A (en) * 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
US5580731A (en) * 1994-08-25 1996-12-03 Chiron Corporation N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
US5681702A (en) * 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US5759776A (en) * 1995-06-05 1998-06-02 California Pacific Medical Center Targets for breast cancer diagnosis and treatment
EP1295952A3 (en) 1996-01-23 2003-07-09 The Board of Trustees of The Leland Stanford Junior University Methods for screening for transdominant effector peptides and RNA molecules
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6074825A (en) * 1997-07-31 2000-06-13 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
US6153441A (en) * 1998-02-17 2000-11-28 Smithkline Beecham Corporation Methods of screening for agonists and antagonists for human CCR7 receptor and CKβ-9 ligand and interaction thereof
US6417208B1 (en) * 1999-02-05 2002-07-09 Albert Einstein College Of Medicine Of Yeshiva University Method of identification of inhibitors of PDE1C
EP1358349A2 (en) 2000-06-05 2003-11-05 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
CA2416292A1 (en) 2000-06-29 2002-01-10 Deltagen, Inc. Transgenic mice containing targeted gene disruptions
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2002022660A2 (en) 2000-09-11 2002-03-21 Hyseq, Inc. Novel nucleic acids and polypeptides
US7820447B2 (en) 2000-12-22 2010-10-26 Sagres Discovery Inc. Compositions and methods for cancer
US20030216558A1 (en) 2000-12-22 2003-11-20 Morris David W. Novel compositions and methods for cancer
WO2003008583A2 (en) 2001-03-02 2003-01-30 Sagres Discovery Novel compositions and methods for cancer
US20030009781A1 (en) 2001-03-29 2003-01-09 Allen Keith D. Transgenic mice containing Kir3.3 potassium channel gene disruptions

Similar Documents

Publication Publication Date Title
JP2006507794A5 (enExample)
JP2005514923A5 (enExample)
KR101651690B1 (ko) Vegf 다형성 및 항―혈관신생 요법
JP2006518991A5 (enExample)
KR20160138494A (ko) Fgfr 융합물
JP2007506426A5 (enExample)
WO2007038402A1 (en) Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas
JP2005512558A5 (enExample)
JP2005522999A5 (enExample)
JP2020520367A5 (enExample)
CN105659085B (zh) 预测受试者对多激酶抑制剂的反应的基因表达标志及其使用方法
JP2003508022A5 (enExample)
CA2362527A1 (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
KR20230025895A (ko) 순환 종양 핵산 분자의 다중모드 분석
JP2008512984A5 (enExample)
JP2005537007A5 (enExample)
JP2002518051A5 (enExample)
JP2004533825A5 (enExample)
KR20170072685A (ko) 삼중음성유방암의 아형 분류 방법
Carinci et al. Genetic portrait of mild and severe lingual dysplasia
JP2005511023A5 (enExample)
JP2005531290A5 (enExample)
JP2005535289A5 (enExample)
JP2005526508A5 (enExample)
JP2006503575A5 (enExample)